Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
In patients with metastatic pancreatic adenocarcinoma, nab-paclitaxel plus gemcitabine significantly improved overall survival, progression-free survival, and response rate, but...